Skip to content

Human Gut Microbiota and microRNA Expression

Regulatory Effect of Stachyose on Gut Microbiota and microRNA Expression in Human

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05392348
Enrollment
36
Registered
2022-05-26
Start date
2022-05-25
Completion date
2022-06-30
Last updated
2022-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gut Microbiota, microRNA

Keywords

stachyose, gut microbiota, microRNA

Brief summary

In this study, stachyose was used as an intervention factor. We will evaluate changes in fecal gut microbiota and miRNA expression profiles in subjects under stachyose intervention

Detailed description

In the stachyose intervention group, each person in the stachyose intervention group took 5 g of stachyose daily before breakfast, and the administration method was 100 ml of drinking water dissolved and taken orally for two months. Each person in the placebo control group took the same amount of maltodextrin daily. Stool samples of the subjects were collected weekly.

Interventions

DIETARY_SUPPLEMENTstachyose

Stachyose is a tetrasaccharide consisting of sucrose having an alpha-D-galactosyl-(1-\>6)-alpha-D-galactosyl moiety attached at the 6-position of the glucose.

DIETARY_SUPPLEMENTMaltodextrin

Maltodextrin is a polysaccharide that is used primarily in foods and beverages as a thickener, sweetener, and/or stabilizer. It is a relatively short-chain polymer (some would call it an oligomer); commercial products contain an average of ≈3 to ≈17 glucose units per chain. It is manufactured by partially hydrolyzing grain starches, usually corn or wheat.

Sponsors

Xijing Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy human

Exclusion criteria

* people who need intake antibiotics,probiotics or its product

Design outcomes

Primary

MeasureTime frameDescription
expression of microRNAup to 4 weekssmall rna sequencing valuated the microRNA expression in human
structure of gut microbiotaup to 4 weeks16S rDNA sequencing valuated the gut microbiota composition in human

Countries

China

Contacts

Primary ContactChao Guo
xysn@163.com029-84775475

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026